Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Densate TM
Active ingredients: alendronate
What it is used for
For the treatment of Osteoporosis. Osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults, or by the presence of osteoporotic fracture.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Store in a Dry Place
- Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White to off-white, oval shaped, biconvex, uncoated tablets debossed with 'F' on one side and '21' on the other side
Food interactions
For the active ingredient alendronate
- Take 30-60 minutes before breakfast.
- Take with a full glass of water.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November 1, 2018. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient alendronate
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
